In support of the role of CIP2A in the MYC promotion of cancerous transformation, Puustinen and Jӓӓttela reported CIP2A as an oncoprotein that promotes MYC- and MTORC1-mediated cancer transformation by inhibiting the autophagy pathway [157]. Here, CIP2A is linked to cancer.